Remed Co.Ltd (302550) — Capital Reinvestment Ratio
Remed Co.Ltd (302550) has a Capital Reinvestment Ratio of 0.21x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩1.01 Billion) in capital expenditures (₩215.97 Million). See debt-free asset ratio of Remed Co.Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Remed Co.Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Remed Co.Ltd's Capital Reinvestment Ratio across 7 annual periods. Check 302550 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Remed Co.Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Remed Co.Ltd from 2017 to 2025. For live market cap and broader valuation context, see market cap of Remed Co.Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | ₩2.40 Billion | ₩868.76 Million | ▼ -25.9% |
| 2024 | 0.49x | ₩1.24 Billion | ₩608.80 Million | ▲ +91.5% |
| 2023 | 0.26x | ₩3.50 Billion | ₩893.97 Million | ▼ -72.1% |
| 2022 | 0.92x | ₩5.21 Billion | ₩4.77 Billion | ▲ +248.9% |
| 2020 | 0.26x | ₩2.59 Billion | ₩679.62 Million | ▼ -57.9% |
| 2019 | 0.62x | ₩3.22 Billion | ₩2.01 Billion | ▼ -94.6% |
| 2017 | 11.52x | ₩66.75 Million | ₩768.89 Million | — |